Planned pivotal phase III trial of danazol in patients with diabetic macular oedema

Trial Profile

Planned pivotal phase III trial of danazol in patients with diabetic macular oedema

Planning
Phase of Trial: Phase III

Latest Information Update: 03 Dec 2012

At a glance

  • Drugs Danazol (Primary)
  • Indications Diabetic macular oedema
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 03 Dec 2012 New trial record
    • 14 Nov 2012 Sites in Europe have been identified for this trial, according to an Ampio Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top